| 000 | 01118 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516225521.0 | ||
| 264 | 0 | _c20141014 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/apt.12850 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCyrany, J | |
| 245 | 0 | 0 |
_aLetter: telmisartan-associated enteropathy - is there any class effect? _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cSep 2014 |
||
| 300 |
_a569-70 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xadverse effects |
| 650 | 0 | 4 |
_aCeliac Disease _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadverse effects |
| 650 | 0 | 4 |
_aTetrazoles _xadverse effects |
| 700 | 1 | _aVasatko, T | |
| 700 | 1 | _aMachac, J | |
| 700 | 1 | _aNova, M | |
| 700 | 1 | _aSzanyi, J | |
| 700 | 1 | _aKopacova, M | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 40 _gno. 5 _gp. 569-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.12850 _zAvailable from publisher's website |
| 999 |
_c24079875 _d24079875 |
||